Aurobindo Pharma gains 3.5% on buyback plans
Aurobindo Pharma shares ended 3.53% higher on Monday in the wake of the drugmaker on Sunday hinting at an impending buyback. The shares closed at ₹1,373.85 apiece on the BSE. In a filing, the company had announced that its board would meet on July 18 to consider, among others, a proposal for buyback of the fully paid-up equity shares of the company and the matters necessary and incidental thereto.
Disclaimer: The copyright of this article belongs to the original
author. Reposting this article is solely for the purpose of information
dissemination and does not constitute any investment advice. If there is
any infringement, please contact us immediately. We will make
corrections or deletions as necessary. Thank you.